abstract: 'Multi-drug resistant tuberculosis (MDR-TB) represents a threat to health and development in countries with high TB burden. China''s MDR-TB prevalence rate of 6.8\% is the highest in the world. Interventions to remove barriers against effective TB control, and prevention of MDR-TB are urgently needed in the country. This paper reports a cross-sectional questionnaire survey of 513 pulmonary TB (PTB) patients, and qualitative interviews of 10 healthcare workers (HCWs), and 15 PTB patients. The objective was to assess barriers against effective control of PTB and prevention of MDR-TB by elucidating the perspectives of patients and healthcare providers. Results showed that more than half of the patients experienced patient delay of over 12.5 days. A similar proportion also experienced detection delay of over 30 days, and delay in initiating treatment of over 31 days. Consulting a non-TB health facility >= 3 times before seeking care at TB dispensary was a risk factor for both detection delay {[}AOR (95\% CI): 1.89(1.07, 3.34) and delay in initiating treatment{[}AOR (95\% CI): 1.88 (1.06, 3.36). Results revealed poor implementation of Directly Observed Therapy (DOT), whereby treatment of 34.3\% patients was never monitored by HCWs. Only 31.8\% patients had ever accessed TB health education before their TB diagnosis. Qualitative data consistently disclosed long patient delay, and indicated that patient''s poor TB knowledge and socioeconomic barriers were primary reasons for patient delay. Seeking care and being treated at a non-TB hospital was an important reason for detection delay. Patient''s long work hours and low income increased risk for treatment non-adherence. Evidence-based measures to improve TB health seeking behavior, reduce patient and detection delays, improve the quality of DOT, address financial and system barriers, and increase access to TB health promotion are urgently needed to address the burgeoning prevalence of MDR-TB in China.' affiliation: 'Li, Y (Corresponding Author), Third Mil Med Univ, Dept Social Med \& Hlth Serv Management, Chongqing, Peoples R China. Li, Ying; Liu, Ying, Third Mil Med Univ, Dept Social Med \& Hlth Serv Management, Chongqing, Peoples R China. Ehiri, John, Univ Arizona, Mel \& Enid Zuckerman Coll Publ Hlth, Div Hlth Promot Sci, Tucson, AZ USA. Oren, Eyal, Univ Arizona, Mel \& Enid Zuckerman Coll Publ Hlth, Div Epidemiol \& Biostat, Tucson, AZ USA. Hu, Daiyu; Wang, Qingya, Chongqing Inst TB Prevent \& Treatment, Chongqing, Peoples R China. Luo, Xingneng, Ctr Dis Control Shapingba Dist, Dept TB Control, Chongqing, Peoples R China. Li, Daikun, Chongqing Med Univ, Univ Town Hosp, Dept Lab Med, Chongqing, Peoples R China.' article-number: e88330 author: Li, Ying and Ehiri, John and Oren, Eyal and Hu, Daiyu and Luo, Xingneng and Liu, Ying and Li, Daikun and Wang, Qingya author-email: lilyliying2012@163.com author_list: - family: Li given: Ying - family: Ehiri given: John - family: Oren given: Eyal - family: Hu given: Daiyu - family: Luo given: Xingneng - family: Liu given: Ying - family: Li given: Daikun - family: Wang given: Qingya da: '2023-09-28' doi: 10.1371/journal.pone.0088330 files: [] issn: 1932-6203 journal: PLOS ONE keywords-plus: 'MULTIDRUG-RESISTANT TUBERCULOSIS; ANTITUBERCULOSIS-DRUG-RESISTANCE; RISK-FACTORS; PULMONARY TUBERCULOSIS; EPIDEMIOLOGY; PREVALENCE; DELAYS; TIME' language: English month: FEB 5 number: '2' number-of-cited-references: '46' orcid-numbers: Oren, Eyal/0000-0001-7817-3516 papis_id: 4b826a6b979a356127bb915a643da864 ref: Li2014arewe researcherid-numbers: 'Oren, Eyal/AAD-5561-2019 ' times-cited: '17' title: Are We Doing Enough to Stem the Tide of Acquired MDR-TB in Countries with High TB Burden? Results of a Mixed Method Study in Chongqing, China type: article unique-id: WOS:000330829200177 usage-count-last-180-days: '0' usage-count-since-2013: '26' volume: '9' web-of-science-categories: Multidisciplinary Sciences year: '2014'